Peter E. Westerweel
Impact in
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Mesenchymal stem cell research
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
Papers in
- Hematology 39
- Chronic Myeloid Leukemia Treatments 32
- Platelet Disorders and Treatments 4
- Genetics 22
- Chronic Lymphocytic Leukemia Research 19
- Co-authors
- Marianne C. Verhaar (18 shared papers)Imo E. Hoefer (3 shared papers)Hein A. Koomans (2 shared papers)Mark‐David Levin (13 shared papers)Jan J. Cornelissen (12 shared papers)Jan de Boer (1 shared paper)Jeroen Rouwkema (1 shared paper)Clemens van Blitterswijk (1 shared paper)
- Journals
- Blood (9 papers)European Journal Of Haematology (4 papers)HemaSphere (4 papers)Leukemia (3 papers)Annals of Hematology (3 papers)
- Partner nations
- NetherlandsGermanyUnited States
In The Last Decade
Peter E. Westerweel
78 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 95
- Genetics 286
- Hematology 266
- Internal Medicine 37
- Rheumatology 160
- Nephrology 50
Countries citing papers authored by Peter E. Westerweel
This map shows the geographic impact of Peter E. Westerweel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter E. Westerweel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter E. Westerweel more than expected).
Fields of papers citing papers by Peter E. Westerweel
This network shows the impact of papers produced by Peter E. Westerweel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter E. Westerweel. The network helps show where Peter E. Westerweel may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter E. Westerweel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 80 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 103 | |
| 2 | 2007 | 96 | |
| 3 | 2007 | 90 | |
| 4 | 2010 | 72 | |
| 5 | 2007 | 71 | |
| 6 | 2013 | 61 | |
| 7 | 2008 | 60 | |
| 8 | 2013 | 59 | |
| 9 | 2019 | 50 | |
| 10 | 2009 | 46 | |
| 11 | 2017 | 45 | |
| 12 | 2005 | 39 | |
| 13 | 2020 | 33 | |
| 14 | 2021 | 32 | |
| 15 | 2023 | 30 | |
| 16 | 2018 | 26 | |
| 17 | 2022 | 24 | |
| 18 | 2005 | 24 | |
| 19 | 2018 | 20 | |
| 20 | 2020 | 19 |
About Peter E. Westerweel
Peter E. Westerweel is a scholar working on Hematology, Genetics, Oncology, Molecular Biology and Pathology and Forensic Medicine, having authored 80 papers that have together received 1.4k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (32 papers), Chronic Lymphocytic Leukemia Research (19 papers), Angiogenesis and VEGF in Cancer (10 papers), Lymphoma Diagnosis and Treatment (9 papers), Acute Lymphoblastic Leukemia research (7 papers), HER2/EGFR in Cancer Research (5 papers), Platelet Disorders and Treatments (4 papers) and Eosinophilic Disorders and Syndromes (4 papers). The work is most often cited by research in Genetics (286 citations), Hematology (266 citations), Internal Medicine (37 citations), Rheumatology (160 citations) and Nephrology (50 citations). Peter E. Westerweel has collaborated with scholars based in Netherlands, Germany and United States. Frequent co-authors include Marianne C. Verhaar, Imo E. Hoefer, Hein A. Koomans, Mark‐David Levin, Jan J. Cornelissen, Jan de Boer, Jeroen Rouwkema, Clemens van Blitterswijk, Ronald H. W. M. Derksen and Jeroen J. W. M. Janssen. Their work appears in journals such as Blood, European Journal Of Haematology, HemaSphere, Leukemia and Annals of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.